PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
83 hedge funds and large institutions have $330M invested in POINT Biopharma Global Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
83
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$23.8M | |
| 2 | +$13.3M | |
| 3 | +$13M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.28M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.46M |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$4.69M | |
| 3 | -$3.26M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.3M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.06M |